2α-Substituted Vitamin D Derivatives Effectively Enhance the Osteoblast Differentiation of Dedifferentiated Fat Cells
Open Access
- 15 June 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (6) , 706
Abstract
The active form of vitamin D3, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], is a principal regulator of calcium homeostasis through activation of the vitamin D receptor (VDR). Previous studies have shown that 2α-(3-hydroxypropyl)-1,25D3 (O1C3) and 2α-(3-hydroxypropoxy)-1,25D3 (O2C3), vitamin D derivatives resistant to inactivation enzymes, can activate VDR, induce leukemic cell differentiation, and increase blood calcium levels in rats more effectively than 1,25(OH)2D3. In this study, to further investigate the usefulness of 2α-substituted vitamin D derivatives, we examined the effects of O2C3, O1C3, and their derivatives on VDR activity in cells and mouse tissues and on osteoblast differentiation of dedifferentiated fat (DFAT) cells, a cell type with potential therapeutic application in regenerative medicine. In cell culture experiments using kidney-derived HEK293 cells, intestinal mucosa-derived CaCO2 cells, and osteoblast-derived MG63 cells, and in mouse experiments, O2C2, O2C3, O1C3, and O1C4 had a weaker effect than or equivalent effect to 1,25(OH)2D3 in VDR transactivation and induction of the VDR target gene CYP24A1, but they enhanced osteoblast differentiation in DFAT cells equally to or more effectively than 1,25(OH)2D3. In long-term treatment with the compound without the medium change (7 days), the derivatives enhanced osteoblast differentiation more effectively than 1,25(OH)2D3. O2C3 and O1C3 were more stable than 1,25(OH)2D3 in DFAT cell culture. These results indicate that 2α-substituted vitamin D derivatives, such as inactivation-resistant O2C3 and O1C3, are more effective than 1,25(OH)2D3 in osteoblast differentiation of DFAT cells, suggesting potential roles in regenerative medicine with DFAT cells and other multipotent cells.Keywords
Funding Information
- Project Research Grant from the Research Committee on Fat-Soluble Vitamins (2013) (S1411018)
- Nihon University School of Medicine Alumni Association 60th Anniversary Fund Research Grant (2015) (S1411018)
- MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411018)
- Nihon University President Grant Initiative (2018–2020) (S1411018)
- Research Grant from the Chairperson and the President of Nihon University (2021–2022) (S1411018)
This publication has 40 references indexed in Scilit:
- Vitamin D and its analogs as anticancer and anti-inflammatory agentsEuropean Journal of Medicinal Chemistry, 2020
- Alternative and complementary therapies in osteoarthritis and cartilage repairAging Clinical and Experimental Research, 2020
- Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)Journal of Bone and Mineral Metabolism, 2020
- The osteoblastic differentiation ability of human dedifferentiated fat cells is higher than that of adipose stem cells from the buccal fat padClinical Oral Investigations, 2013
- Molecular Mechanisms of Vitamin D ActionCalcified Tissue International, 2012
- Effects of γ-secretase inhibition on the proliferation and vitamin D3 induced osteogenesis in adipose derived stem cellsBiochemical and Biophysical Research Communications, 2010
- Mature adipocyte-derived dedifferentiated fat cells can transdifferentiate into skeletal myocytes in vitroBiochemical and Biophysical Research Communications, 2008
- Mature adipocyte‐derived dedifferentiated fat cells exhibit multilineage potentialJournal of Cellular Physiology, 2007
- A novel preadipocyte cell line established from mouse adult mature adipocytesBiochemical and Biophysical Research Communications, 2004
- Effects of 1?-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosisCalcified Tissue International, 1994